According to Relmada Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:25 PM, company CEO, Traversa Sergio disclosed selling 1,930 shares at a cost of $35.28. At the time of this transaction (Feb 10), this trade was worth $68,097 in total. As of […]
According to Relmada Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:25 PM, company CEO, Traversa Sergio disclosed selling 5,963 shares at a cost of $35.21. At the time of this transaction (Feb 09), this trade was worth $209,939 in total. As of […]
According to Relmada Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:25 PM, company CEO, Traversa Sergio disclosed selling 3,313 shares at a cost of $35.03. At the time of this transaction (Feb 08), this trade was worth $116,049 in total. As of […]
According to Relmada Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:25 PM, company Director, Kelly Paul Edward disclosed selling 2,069 shares at a cost of $35.29. At the time of this transaction (Feb 09), this trade was worth $73,005 in total. As […]
According to Relmada Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:25 PM, company Director, Kelly Paul Edward disclosed selling 1,500 shares at a cost of $35.04. At the time of this transaction (Feb 08), this trade was worth $52,560 in total. As […]
According to Relmada Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:25 PM, company CFO, Shenouda Maged disclosed selling 2,410 shares at a cost of $35.20. At the time of this transaction (Feb 10), this trade was worth $84,825 in total. As of […]
According to Relmada Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:25 PM, company CFO, Shenouda Maged disclosed selling 5,359 shares at a cost of $35.24. At the time of this transaction (Feb 09), this trade was worth $188,843 in total. As of […]
According to Relmada Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:25 PM, company CFO, Shenouda Maged disclosed selling 3,603 shares at a cost of $35.04. At the time of this transaction (Feb 08), this trade was worth $126,242 in total. As of […]
According to Mesa Laboratories Inc /Co/’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:24 PM, company Director, Schmieder John Bradley disclosed selling 1,750 shares at a cost of $278.23. At the time of this transaction (Feb 10), this trade was worth $486,903 in total. […]
According to Svb Financial Group’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:23 PM, company Director, Mitchell Kate disclosed selling 3,985 shares at a cost of $499.00. At the time of this transaction (Feb 08), this trade was worth $1,988,515 in total. As of […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
